Sihuan Bio to acquire 80% stake in Changyuan Pharmaceutical for 160 million yuan

M&A · Partnership
โดย 央广财经·CN·Read original
Summary · why it matters

Sihuan Bio announced plans to acquire an 80% stake in Jilin Changyuan Pharmaceutical in cash for 160 million yuan. The target company is mainly engaged in pharmaceutical production and sales, with its core product being succinylated gelatin injection. The transaction is still in the planning stage, and there is uncertainty as to whether it will ultimately be completed.

Impact on stocks 1

Others▲ · 1 stocks

Off-coverage companies 1

Jilin Changyuan Pharmaceutical Co., Ltd.Private± Mixed
Capitalrelevance

Changyuan Pharmaceutical is the target of acquisition; impact depends on deal completion and terms.

© 2026 MarketDXNews